Apoptosis-related factors are relevant to progression of pancreatic neuroendocrine tumors
Shota Amano, Teijiro Hirashita, Yoko Kawano, Haruto Nishida, Hiroki Orimoto, Masahiro Kawamura, Takahide Kawasaki, Takashi Masuda, Yuichi Endo, Masayuki Ohta, Tsutomu Daa, Masafumi Inomata · 2023
Read Apoptosis-related factors are relevant to progression of pancreatic neuroendocrine tumors by Shota Amano, Teijiro Hirashita, Yoko Kawano, Haruto Nishida, Hiroki Orimoto, Masahiro Kawamura, Takahide Kawasaki, Takashi Masuda, Yuichi Endo, Masayuki Ohta, Tsutomu Daa, Masafumi Inomata (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714622.txt.
Description
Shota Amano and eleven colleagues published a 2023 study on tumors of the pancreas called pancreatic neuroendocrine tumors. These tumors grow from hormone-making cells. When they cannot be cut out, drug therapy is the main path, but picking the best drug is unsettled.
The team reviewed 47 patients who had surgery for these tumors. They stained tumor samples for a set of markers tied to cell death, called apoptosis. One marker, GLUT1, tracks sugar uptake, while others mark drug targets on the cell surface. They asked which markers track how the tumor advances. Clear markers could help doctors match each patient to the drug most likely to help.
Catalog record
| CREATOR | Shota Amano, Teijiro Hirashita, Yoko Kawano, Haruto Nishida, Hiroki Orimoto, Masahiro Kawamura, Takahide Kawasaki, Takashi Masuda, Yuichi Endo, Masayuki Ohta, Tsutomu Daa, Masafumi Inomata |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |